Abstract
The term 'giant prolactinoma' can be used for tumours larger than 4 cm in diameter and/or with massive extrasellar extension. Cabergoline (CAB), a long-lasting dopamine agonist (DA), safe and well tolerated, is effective in normalizing PRL levels and inducing tumour shrinkage in micro- and macroprolactinomas. The purpose of this prospective study was to evaluate the efficacy and safety of CAB also for giant prolactinomas.
Lingua originale | English |
---|---|
pagine (da-a) | 662-670 |
Numero di pagine | 9 |
Rivista | Clinical Endocrinology |
Volume | 58 |
Stato di pubblicazione | Pubblicato - 2003 |
Keywords
- Adrenal Glands
- Adult
- Aged
- Antineoplastic Agents
- Erectile Dysfunction
- Ergolines
- Humans
- Hypothyroidism
- Libido
- Magnetic Resonance Imaging
- Male
- Middle Aged
- Pituitary Gland
- Pituitary Neoplasms
- Prolactin
- Prolactinoma
- Vision Disorders